Immune thrombocytopenia (ITP) is a rare autoimmune condition, due to peripheral platelet
destruction through antibody-dependent cellular phagocytosis, complement-dependent …

Immune thrombocytopenia (ITP) is a rare autoimmune disorder with an incidence of 3 to 5
per 100 000 individuals. In children, the disease is self-limited and is most commonly virus …

Immune thrombocytopenia, or ITP, has been recognized as a clinical entity for centuries, and
the importance of humoral mechanisms in the pathophysiology of ITP has been recognized …

Immune thrombocytopenia (ITP) is a rare autoimmune disease due to both a peripheral
destruction of platelets and an inappropriate bone marrow production. Although the primary …

Immune thrombocytopenia (ITP) is a complex autoimmune disease characterized by low
platelet counts. The pathogenesis of ITP remains unclear although both antibody-mediated …

Traditional treatment of primary (idiopathic) immune thrombocytopenia (ITP) predominantly
consists of immune suppression and/or modulation. In addition, many treated patients …

Immune thrombocytopenia (ITP) is an autoimmune disease characterized by an isolated
decrease in the platelet count and an increased risk of bleeding. The pathogenesis is …

Although the development and regulatory approval of the thrombopoietin receptor agonists
revolutionized aspects of the immune thrombocytopenia (ITP) treatment landscape over the …

Objectives: Classically, immune thrombocytopenia (ITP) was thought to be caused by the
destruction and insufficient production of platelets, as mediated by autoantibodies. More …

Immune thrombocytopenia (ITP) is an autoimmune disorder characterized by antibody-
mediated platelet destruction. The platelet, as an accessible target, has made ITP an …